【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 9
2 Introduction 10
2.1 Hydrogels Overview 10
3 Products under Development 11
3.1 Hydrogels – Pipeline Products by Stage of Development 11
3.2 Hydrogels – Pipeline Products by Segment 12
3.3 Hydrogels – Pipeline Products by Territory 13
3.4 Hydrogels – Pipeline Products by Regulatory Path 14
3.5 Hydrogels – Pipeline Products by Estimated Approval Date 15
3.6 Hydrogels – Ongoing Clinical Trials 16
4 Hydrogels – Pipeline Products under Development by Companies 17
4.1 Hydrogels Companies – Pipeline Products by Stage of Development 17
4.2 Hydrogels – Pipeline Products by Stage of Development 19
5 Hydrogels Companies and Product Overview 21
5.1 3QMatrix, Inc. Company Overview 21
5.1.1 3QMatrix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
5.2 Abeona Therapeutics, Inc. Company Overview 22
5.2.1 Abeona Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 22
5.3 Alafair Biosciences, Inc. Company Overview 24
5.3.1 Alafair Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 24
5.4 Asana Medical, Inc. Company Overview 29
5.4.1 Asana Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
5.5 BioCure, Inc. Company Overview 30
5.5.1 BioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
5.6 Biomendics, LLC Company Overview 34
5.6.1 Biomendics, LLC Pipeline Products & Ongoing Clinical Trials Overview 34
5.7 BioTime, Inc. Company Overview 35
5.7.1 BioTime, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
5.8 Brigham and Women’s Hospital Company Overview 37
5.8.1 Brigham and Women’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 37
5.9 CelaCare Technologies, Inc. Company Overview 38
5.9.1 CelaCare Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38
5.10 Chi2Gel Ltd. Company Overview 41
5.10.1 Chi2Gel Ltd. Pipeline Products & Ongoing Clinical Trials Overview 41
5.11 Consejo Superior de Investigaciones Cientificas Company Overview 42
5.11.1 Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview 42
5.12 Corium International, Inc. Company Overview 44
5.12.1 Corium International, Inc. Pipeline Products & Ongoing Clinical Trials Overview 44
5.13 Edixomed Ltd Company Overview 46
5.13.1 Edixomed Ltd Pipeline Products & Ongoing Clinical Trials Overview 46
5.14 FzioMed, Inc. Company Overview 54
5.14.1 FzioMed, Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
5.15 Halscion, Inc. Company Overview 57
5.15.1 Halscion, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
5.16 HyperBranch Medical Technology, Inc. Company Overview 60
5.16.1 HyperBranch Medical Technology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60
5.17 InVivo Therapeutics Corporation Company Overview 61
5.17.1 InVivo Therapeutics Corporation Pipeline Products & Ongoing Clinical Trials Overview 61
5.18 IPI Singapore Company Overview 62
5.18.1 IPI Singapore Pipeline Products & Ongoing Clinical Trials Overview 62
5.19 KeraNetics, LLC Company Overview 64
5.19.1 KeraNetics, LLC Pipeline Products & Ongoing Clinical Trials Overview 64
5.20 Maxigen Biotech Inc. Company Overview 66
5.20.1 Maxigen Biotech Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
5.21 Medtric Biotech, LLC Company Overview 68
5.21.1 Medtric Biotech, LLC Pipeline Products & Ongoing Clinical Trials Overview 68
5.22 Newcastle University Company Overview 69
5.22.1 Newcastle University Pipeline Products & Ongoing Clinical Trials Overview 69
5.23 Northwestern University Company Overview 70
5.23.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 70
5.24 Oculus Innovative Sciences, Inc. Company Overview 73
5.24.1 Oculus Innovative Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 73
5.25 Oxtex Limited Company Overview 76
5.25.1 Oxtex Limited Pipeline Products & Ongoing Clinical Trials Overview 76
5.26 Pharmagenix AG Company Overview 77
5.26.1 Pharmagenix AG Pipeline Products & Ongoing Clinical Trials Overview 77
5.27 Piramal Enterprises Limited Company Overview 78
5.27.1 Piramal Enterprises Limited Pipeline Products & Ongoing Clinical Trials Overview 78
5.28 Plurogen Therapeutics, Inc. Company Overview 80
5.28.1 Plurogen Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 80
5.29 Quick-Med Technologies, Inc. Company Overview 81
5.29.1 Quick-Med Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
5.30 Surgical Specialties Corporation (Inactive) Company Overview 83
5.30.1 Surgical Specialties Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 83
5.31 Tel Aviv University Company Overview 84
5.31.1 Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview 84
5.32 The Johns Hopkins University Company Overview 85
5.32.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 85
5.33 The University of Queensland Company Overview 86
5.33.1 The University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 86
5.34 University of Akron Company Overview 88
5.34.1 University of Akron Pipeline Products & Ongoing Clinical Trials Overview 88
5.35 University of California, San Diego Company Overview 89
5.35.1 University of California, San Diego Pipeline Products & Ongoing Clinical Trials Overview 89
5.36 Ventrix, Inc. Company Overview 90
5.36.1 Ventrix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 90
5.37 Zeomedix, LLC Company Overview 91
5.37.1 Zeomedix, LLC Pipeline Products & Ongoing Clinical Trials Overview 91
6 Hydrogels- Recent Developments 92
7 Appendix 106
7.1 Methodology 106
7.2 About GlobalData 108
7.3 Contact Us 109
7.4 Disclaimer 109
【レポート販売概要】
■ タイトル:世界におけるヒドロゲルの製品パイプライン動向2015■ 英文:Hydrogels - Pipeline Review, 2015
■ 発行日:2015年9月4日
■ 調査会社:GlobalData
■ 商品コード:GDME0061EPD
■ 調査対象地域:グローバル
- 世界の鉄鋼(Steel)市場予測:建設、自動車、機械、家電、エネルギー、金属製品、造船分野用途Visiongain predicts the world steel market will reach $1.15 trillion in 2014. The construction, automobile, and white goods industries will attract a high demand for steel over the next decade. Vast opportunities exist where the unique properties of steel are critical. This could result in a much larger market penetration. Global steel demand over the next decade will largely depend on the emergin …
- 液体分配装置の世界市場分析:製品別(フラックス、潤滑剤、はんだペースト、接着剤およびシーラント(エポキシ接着剤、エポキシアンダーフィル)、絶縁保護コーティング)、用途別(電気・電子(半導体実装、プリント基板)、医療機器、自動車、建設)、セグメント予測The global fluid dispensing systems market is expected to reach USD 55.09 billion by 2024, according to a new report by Grand View Research, Inc. Growing electronic components manufacturing in Southeast Asia to drive growth. The trend towards miniaturization of electronic components and industry automation are key growth driving factors for the global fluid dispensing systems market. Recent innova …
- Gazprom:石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Gazprom Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Gazprom Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operational data, a …
- 世界のWANアプリケーションデリバリー市場動向(2014-2018)About WAN Application Delivery An application delivery network is a set of technologies used for efficient computing and delivery of applications and data to end-user systems. WAN application delivery is a combination of WAN application delivery controllers and supporting applications. WAN applications encompass various solutions such as traffic management, resource optimization, content managemen …
- 心調律管理(CRM)医療装置のグローバル市場(2012-2018)The Cardiac Rhythm Management Devices market value is expected to reach US$20.9 billion by 2017, primarily supported by the product types - Cardiac Defibrillators, Cardiac Pacemakers Devices and Cardiac Resynchronization Therapy. Globally, Cardiac Defibrillators and Pacemakers Devices together account for approximately 80% of the market share to support the Cardiac Rhythm Management Devices Indust …
- モバイル決済のグローバル市場:新トレンド及び未来展望• The report examines the extent of mobile phone use for payment transactions • The report analyzes the percentage changes expected in payments through mobile phones until mid-2015 • The report identifies major factors influencing increased use of mobile payments by customers • The report determines the key reasons behind the growth in the use and acceptance of mobile payments • The report identif …
- 自動運転車(AV)技術開発企業上位20社2016This revolutionary report from market intelligence provider visiongain offers comprehensive insight into the top 20 companies developing autonomous vehicles in 2016. Benefits of This Report This 136 page report examines the 20 leading companies within the Autonomous vehicle market. In detail, providing the reader with a comprehensive overview of the leading OEMs and technology providers with an an …
- コンプレッサー(圧縮機)の世界市場2016-2020About Compressors Compressors are mechanical devices that compress air or gas in a sealed unit and deliver it at the desired pressure levels. Compressors are categorized as air compressors and gas compressors. An air compressor is a device that compresses and pressurizes air and thereby, converts its potential energy into kinetic energy. A gas compressor is a device that reduces the volume of gas …
- 中国のCOPD治療薬市場2016-2020About the Chronic Obstructive Pulmonary Disease (COPD) Drugs Market in China Chronic obstructive pulmonary disease (COPD) is a broad term that covers progressive lung diseases, including emphysema, chronic bronchitis, refractory (non-reversible) asthma, and some forms of bronchiectasis. It restricts airflow in the lungs and is characterized by diffculty breathing. The exact etiology of COPD is not …
- グローバルにおけるスマートグリッド市場動向:May 2014Smart Grid Review - May 2014 Summary A substantial number of smart grid developments took place in April 2014, including product launches, fundraising events and the announcement and completion of contracts and projects. A total of 13 major acquisitions took place in April. A total of seven contracts were completed between April and May 2014. Some of the key players that won contracts were Siemens …
- Clayton Williams Energy, Inc.:石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Clayton Williams Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Clayton Williams Energy, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an …
- ICT調達動向:メディア産業部門 – 企業のICT投資計画Why was the report written? To highlight the criteria on which media companies select their ICT providers as well as the roles which have influence while making ICT purchasing decisions. What is the current market landscape and what is changing? Media companies have been optimistic about their ICT investments in 2013, preferring to buy technologies direct from suppliers and deploying them on-site. …
- 中小企業向けクラウドサービスの世界市場:パブリッククラウド、プライベートクラウド、ハイブリッドクラウドAbout SME Cloud The adoption of cloud-based services is increasing worldwide. Many large enterprises are already experiencing the benefits of using cloud-based technology for their business operations. The scenario is shifting toward SMEs because they can avoid investment on IT infrastructure and reduce operational costs by adopting cloud-based technology for their daily business operations. Cloud …
- 3D・4D技術の世界市場:3Dカメラ、3Dスキャナー、3Dセンサー、HMD、3Dスマートフォン、3Dグラス、3Dプロジェクター、3Dプリンター、3Dゲーム、3D映画、3Dナビゲーション、3Dアニメーション、3Dモーションキャプチャー、3D計測、3Dジェスチャー認識、4DプリンティングThe total market for 3D & 4D Technology is expected to reach USD 314.17 Billion by 2022, at a CAGR of 16.17% between 2016 and 2022. The major drivers for the growth of 3D content is the entertainment & animation industry and the growing CAD-based manufacturing of individualized custom parts and components. Out of the major end-user industries, the market for military & defense is expected to grow, …
- 5Gインフラストラクチャの世界市場予測(~2027年)“5G infrastructure market projected to grow at 67.1% CAGR during 2019–2027” The 5G infrastructure market is estimated to be valued at USD 784 million in 2019 and is projected to reach USD 47,775 million by 2027, at a CAGR of 67.1%. Lower latency in 5G, growing adoption of virtual networking architecture in telecommunications, and growth in mobile data traffic are among the major driving factors fo …